Resumen: multi-criteria decision analysis (MCDA) is a tool that systematically considers multiple factors relevant to health decision-making. The aim of this study was to use an MCDA to assess the value of dupilumab for severe atopic dermatitis compared with secukinumab for moderate to severe plaque psoriasis in Spain.
Cómo citar: Zozaya González, N., Martínez-Galdeano, L., Alcalá Revilla, B., Armario-Hita, J. C., Carmona, C., Carrascosa, J. M., … & Hidalgo-Vega, Á. (2018). Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis. BioDrugs, 1-11.